From IMU memory, trial cost per patient USD 100k to 200k, depending on procedure and trial design, location, cancer type....
But some previous anns stated that IVX won't have to pay anything for some type of trials, the big Chinese Investment company does it in return for global rights or something similar.
It's early morning, old man on his "Pee-Round", so please forgive any inaccuracies.
GLTA
Ann: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC, page-13
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $32.12M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $4.5K | 1.1M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 10297949 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5917812 | 26 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |